NO20016378D0 - Quinolinkarboksylsyrederivater eller salter derav - Google Patents

Quinolinkarboksylsyrederivater eller salter derav

Info

Publication number
NO20016378D0
NO20016378D0 NO20016378A NO20016378A NO20016378D0 NO 20016378 D0 NO20016378 D0 NO 20016378D0 NO 20016378 A NO20016378 A NO 20016378A NO 20016378 A NO20016378 A NO 20016378A NO 20016378 D0 NO20016378 D0 NO 20016378D0
Authority
NO
Norway
Prior art keywords
carboxylic acid
salts
acid derivatives
quinoline carboxylic
extremely high
Prior art date
Application number
NO20016378A
Other languages
English (en)
Other versions
NO321803B1 (no
NO20016378L (no
Inventor
Akira Yazaki
Yoshiko Niino
Yasuhiro Kuramoto
Yuzo Hirao
Yoshihiro Ohshita
Norihiro Hayashi
Hirotaka Amano
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of NO20016378D0 publication Critical patent/NO20016378D0/no
Publication of NO20016378L publication Critical patent/NO20016378L/no
Publication of NO321803B1 publication Critical patent/NO321803B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20016378A 1999-07-01 2001-12-27 Kinolinkarboksylsyrederivater eller salter derav, medikament eller medikamentblanding som omfatter dem, samt anvendelse derav NO321803B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (3)

Publication Number Publication Date
NO20016378D0 true NO20016378D0 (no) 2001-12-27
NO20016378L NO20016378L (no) 2002-02-28
NO321803B1 NO321803B1 (no) 2006-07-03

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016378A NO321803B1 (no) 1999-07-01 2001-12-27 Kinolinkarboksylsyrederivater eller salter derav, medikament eller medikamentblanding som omfatter dem, samt anvendelse derav

Country Status (25)

Country Link
US (1) US6858625B1 (no)
EP (1) EP1193266B1 (no)
JP (1) JP3477465B2 (no)
KR (1) KR100628414B1 (no)
CN (1) CN1157389C (no)
AT (1) ATE248162T1 (no)
AU (1) AU766014B2 (no)
BR (1) BR0012192A (no)
CA (1) CA2376760C (no)
CZ (1) CZ302033B6 (no)
DE (1) DE60004846T2 (no)
DK (1) DK1193266T3 (no)
ES (1) ES2206257T3 (no)
HK (1) HK1047103B (no)
HU (1) HUP0201549A3 (no)
IL (2) IL147043A0 (no)
MX (1) MXPA02000103A (no)
NO (1) NO321803B1 (no)
NZ (1) NZ516201A (no)
PT (1) PT1193266E (no)
RU (1) RU2236408C2 (no)
SK (1) SK285814B6 (no)
TW (1) TW576832B (no)
WO (1) WO2001002390A1 (no)
ZA (1) ZA200110357B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6868700A (en) 1999-09-02 2001-04-10 Wakunaga Pharmaceutical Co., Ltd Quinolinecarboxylic acid derivative or its salt
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
PT1813610E (pt) * 2004-11-17 2010-10-11 Wakunaga Pharma Co Ltd Novos derivados de ácido piridonacarboxílico ou seus sais
BRPI0919241B8 (pt) * 2008-09-24 2021-05-25 Melinta Subsidiary Corp processo para fabricação de compostos de quinolona, e composição compreendendo composto de quinolona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
JP2758722B2 (ja) 1993-08-13 1998-05-28 ドング ホワ ファーマシューチカル インダストリアル カンパニー，リミテッド 新規キノロンカルボン酸誘導体
CA2290712C (en) * 1995-09-22 2003-09-09 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
ES2224235T3 (es) * 1996-04-19 2005-03-01 Wakunaga Pharmaceutical Co., Ltd. Nuevos derivados del acido piridonacarboxilico o sus sales y agentes antibacterianos que contienen los mismos como ingredientes activos.
DE69724140T2 (de) 1996-11-28 2004-06-03 Wakunaga Pharmaceutical Co., Ltd. Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
AU766014B2 (en) 2003-10-09
HUP0201549A2 (en) 2002-08-28
CZ20014598A3 (cs) 2002-05-15
KR100628414B1 (ko) 2006-09-26
IL147043A0 (en) 2002-08-14
NO321803B1 (no) 2006-07-03
CA2376760C (en) 2008-11-25
EP1193266A1 (en) 2002-04-03
DE60004846D1 (de) 2003-10-02
HK1047103A1 (en) 2003-02-07
EP1193266A4 (en) 2002-08-14
HUP0201549A3 (en) 2003-11-28
HK1047103B (zh) 2005-04-08
DE60004846T2 (de) 2004-06-03
IL147043A (en) 2007-07-04
SK19162001A3 (sk) 2002-06-04
WO2001002390A1 (fr) 2001-01-11
CZ302033B6 (cs) 2010-09-08
DK1193266T3 (da) 2003-11-24
ATE248162T1 (de) 2003-09-15
ES2206257T3 (es) 2004-05-16
AU5567900A (en) 2001-01-22
TW576832B (en) 2004-02-21
CN1358183A (zh) 2002-07-10
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
EP1193266B1 (en) 2003-08-27
CN1157389C (zh) 2004-07-14
CA2376760A1 (en) 2001-01-11
BR0012192A (pt) 2002-06-18
MXPA02000103A (es) 2003-07-21
PT1193266E (pt) 2003-12-31
US6858625B1 (en) 2005-02-22
SK285814B6 (sk) 2007-08-02
NZ516201A (en) 2003-06-30
JP3477465B2 (ja) 2003-12-10
RU2236408C2 (ru) 2004-09-20
ZA200110357B (en) 2002-12-18

Similar Documents

Publication Publication Date Title
AR048859A1 (es) Utilizacion de derivados de indazol carboxamidas para la preparacion de un medicamento destinado al tratamiento y a la prevencion del paludismo
ATE309194T1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
HUP0400781A2 (hu) Eljárás (R)- vagy (S)-lansoprazol kristályosítására, az előállított kristályok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
PL4065564T3 (pl) Pochodne kwasu [(1,5-difenylo-1H-1,2,4-triazol-3-ilo)oksy] octowego i ich sole, zawierające je środki chroniące rośliny użytkowe lub uprawne, sposoby ich wytwarzania i zastosowania jako sejfnery
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
DK0609606T3 (no)
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
KR870006034A (ko) 항균제로서의 5-아미노 및 5-하이드록시- 6,8-디플루오로퀴놀론
NO884958L (no) Kinolinkarboksylsyrederivater.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
IL101009A0 (en) 2-substituted quinolines,preparation and pharmaceutical compositions containing them
NO20016378D0 (no) Quinolinkarboksylsyrederivater eller salter derav
KR950700281A (ko) 퀴놀론카르복실산 유도체 수화물 결정(crystal of quinolonecarboxylic acid derivative hydrate)
DE602004009079D1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
JP3424038B2 (ja) 合成抗菌剤水性組成物
JPS63188626A (ja) ピリドンカルボン酸の可溶化方法
HUP0302256A2 (hu) Csökkentett savtartalmú és tároláskor stabil ciprofloxacin infúzió és eljárás az előállítására
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
KR920006345A (ko) 신규한 퀴놀론 카르복실산 유도체
MXPA04000952A (es) Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees